Cargando…

Possible Interaction between Dabigatran and Ranolazine in Patients with Renal Failure

Dabigatran etexilate is a direct oral anticoagulant (thrombin inhibitor) used for the prevention of stroke and systemic thromboembolic events in patients with permanent atrial fibrillation; prevention of venous thromboembolic events and deep veins thrombosis; treatment and prevention of pulmonary em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gumbrevičius, Gintautas, Damulevičienė, Gytė, Galaunė, Vaidotas, Gumbrevičiūtė, Milda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023236/ https://www.ncbi.nlm.nih.gov/pubmed/31905748 http://dx.doi.org/10.3390/medicina56010013

Ejemplares similares

The Glomerular Filtration Rate Estimators in the Pharmacokinetic Modelling in Acute Kidney Injury: An Observational Study
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Ranolazine Induced Bradycardia, Renal Failure, and Hyperkalemia: A BRASH Syndrome Variant
por: Zaidi, Syed Arsalan Akhter, et al.
Publicado: (2019)

Oropharyngeal Dysphagia as the Main Expression of Amyotrophic Lateral Sclerosis
por: Rugaitienė, Margarita, et al.
Publicado: (2022)

Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Impaired Subjective Visual Vertical and Increased Visual Dependence in Older Adults With Falls
por: Totilienė, Milda, et al.
Publicado: (2021)

A Rare Neurological Complication of Ranolazine
por: Porhomayon, Jahan, et al.
Publicado: (2013)

Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014)

Keratolysis exfoliativa-like eruption induced by ranolazine
por: Pierobon, Elena, et al.
Publicado: (2022)

COVID-19-related arrhythmias and the possible effects of ranolazine
por: Chukwunyere, Ugochukwu, et al.
Publicado: (2021)

Ranolazine can markedly increase tacrolimus blood levels
por: Seck, Sidy, et al.
Publicado: (2011)

A novel oral anticoagulant, dabigatran, in acute renal infarction
por: Altın, Cihan, et al.
Publicado: (2015)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

A Case Report of Rivaroxaban-Induced Urticaria and Angioedema With Possible Cross-Reaction to Dabigatran
por: Patil, Tanvi, et al.
Publicado: (2019)

Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function
por: Maw, Thin Thin, et al.
Publicado: (2014)

Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3
por: Tan, Reina Bianca, et al.
Publicado: (2016)

Dabigatran Associated Leukocytoclastic Vasculitis
por: Potolidis, Evangelos, et al.
Publicado: (2015)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report
por: Menichelli, Danilo, et al.
Publicado: (2023)

Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm
por: Margos, Panagiotis, et al.
Publicado: (2017)

Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014)

Ranolazine: A Contemporary Review
por: Rayner‐Hartley, Erin, et al.
Publicado: (2016)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Older Adults—Potential Users of Technologies
por: Lesauskaitė, Vita, et al.
Publicado: (2019)

Anticoagulant Related Nephropathy Induced by Dabigatran
por: Sharfuddin, Nazia, et al.
Publicado: (2018)

Dabigatran-Induced Massive Spontaneous Hemothorax
por: Huang, Jing, et al.
Publicado: (2017)

Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery
por: Parli, Sara E., et al.
Publicado: (2016)

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
por: Glund, Stephan, et al.
Publicado: (2018)

Dabigatran Excess: Case Report and Review of the Literature
por: Sarma, Amy, et al.
Publicado: (2013)

Thrombus Formation in Left Atrium on Dabigatran Therapy
por: Shah, Priyank, et al.
Publicado: (2015)

Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage
por: Balakumar, Jonathan, et al.
Publicado: (2017)

Thrombocytopenia induced by dabigatran: two case reports
por: Kang, Hyun Goo, et al.
Publicado: (2017)

Dabigatran-etexilate: Lack of efficacy: case report
Publicado: (2021)

Ranolazine Interacts Antagonistically with Some Classical Antiepileptic Drugs—An Isobolographic Analysis
por: Borowicz-Reutt, Kinga, et al.
Publicado: (2022)

Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report
por: Murdock, David K, et al.
Publicado: (2011)

Improvement of Vascular Insulin Sensitivity by Ranolazine
por: Guerra-Ojeda, Sol, et al.
Publicado: (2023)

Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran
por: Held, Valentin, et al.
Publicado: (2016)

Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021)

Dabigatran‐induced esophagitis with full circumferential blue pigmentation
por: Araki, Tomonori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjfocmb6mqu2gf62uhrofm0rmu